Covid 19 Infection - McAllen TX

Summary:

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.

Inclusion Criteria

• Are currently not hospitalized
• Have one or more mild or moderate COVID-19 symptoms: Fever, cough, sore throat, malaise, headache, muscle pain, gastrointestinal symptoms, or shortness of breath with exertion
• Must have sample taken for test confirming viral infection no more than 3 days prior to starting the drug infusion
• Are males or non-pregnant females who agree to contraceptive requirements
• Understand and agree to comply with planned study procedures
• Agree to the collection of nasopharyngeal swabs and venous blood
• The participant or legally authorized representative give signed informed consent and/or assent

• Are greater than or equal to (≥)18 years of age and must satisfy at least one of the following at the time of screening

  • Are ≥65 years of age
  • Have a body mass index (BMI) ≥35
  • Have chronic kidney disease (CKD)
  • Have type 1 or type 2 diabetes
  • Have immunosuppressive disease
  • Are currently receiving immunosuppressive treatment or

  • Are ≥55 years of age AND have:

    • cardiovascular disease (CVD), OR
    • hypertension, OR
    • chronic obstructive pulmonary disease (COPD) or other chronic respiratory diseas

Qualified Participants May Receive:

Compesation for your time and travel expenses besides free medication.